1.Correlation between VEGF-C expression in peripheral blood, lymph nodes and tumor tissues in patients with non-small cell lung cancer.
Hong-sheng ZENG ; Qi-sen GUO ; Yan GUAN
Chinese Journal of Oncology 2011;33(7):527-528
Adult
;
Aged
;
Carcinoma, Non-Small-Cell Lung
;
metabolism
;
pathology
;
Female
;
Humans
;
Lung Neoplasms
;
metabolism
;
pathology
;
Lymph Nodes
;
metabolism
;
pathology
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
Neoplasm Staging
;
RNA, Messenger
;
metabolism
;
Vascular Endothelial Growth Factor C
;
blood
;
genetics
;
metabolism
2.Design, synthesis and antalgic activities of aralkyl-ketone-4-piperidol derivatives.
Guan WANG ; Gui-sen ZHANG ; Lin GUO ; Jie CHEN ; Jian-qi LI
Acta Pharmaceutica Sinica 2009;44(4):371-378
A series of aralkyl-ketone-4-piperidol derivatives were synthesized and tested for their analgesic activities. All of the novel 30 compounds were prepared from 4-piperidone and alpha-halo-aralkyl-ketone through five steps, including Boc protection, nucleophilic addition in presence of CeCl3/NaI catalyst, deprotection, condensation and salification. Their structures were confirmed by 1H NMR and HRMS. Preliminary in vivo pharmacological trials showed that most of the synthesized compounds revealed analgesic effects. Among the tested compounds, 8, 13 and 22 exhibited potent analgesic activities in both mice writhing and mice hot plate model. The three compounds have low affinity for mu, delta, kappa receptors, which is a chance to find a better precursor of non-opioid analgesic for further optimization.
Analgesics, Non-Narcotic
;
chemical synthesis
;
chemistry
;
pharmacology
;
Animals
;
Mice
;
Molecular Structure
;
Pain Measurement
;
Pain Threshold
;
drug effects
;
Piperidones
;
chemical synthesis
;
chemistry
;
pharmacology
;
Receptors, Opioid, delta
;
metabolism
;
Receptors, Opioid, kappa
;
metabolism
;
Receptors, Opioid, mu
;
metabolism
;
Structure-Activity Relationship
4.Down-regulation of TopI by RNA interference reduces the drug-sensitivity of small cell lung cancer cell lines to topotecan.
Xiu-ju LIU ; Qi-sen GUO ; Qiong ZHANG ; Xian-rang SONG ; Yong-lei LIU ; Chen GUO
Chinese Journal of Oncology 2008;30(10):741-744
OBJECTIVETo investigate the expressions of TopI gene in small cell lung cancer cell line H446, and explore the influence of TopI on the chemosensitivity of the cell line to topotecan (TPT).
METHODSWestern blot was performed to detect the TopI expression in H446 cells. Lipofectamine 2000 was used for the transient transfection of H446 cells by siRNA, and the transfection efficacy was detected. TopI mRNA was analyzed by quantitative RT-PCR and TopI protein was detected by Western blot to selected effective siRNA. The drug-sensitivity to topotecan (TPT) was evaluated by MTT assay.
RESULTSTopI gene was expressed in H446 cells. Lipofectamine 2000 mediated the siRNA effectively (88.67%). Compared with its parental cells, RT-PCR results showed that TopI mRNAs in transfected cells were reduced by (95.7 +/- 1.6)%, (90.8 +/- 1.6)%, (96.1 +/- 2.7)% and (96.3 +/- 1.8)%, respectively, and decreased significantly at protein level. By MTT assay, the inhibition rate of TPT to H446 cells transfected by siRNA was lower than that of control group at same concentrations (P < 0.01).
CONCLUSIONsiRNAs can silence the expression of TopI and decrease the drug-sensitivity of H446 cells to TPT.
Antineoplastic Agents ; pharmacology ; Cell Line, Tumor ; Cell Proliferation ; drug effects ; DNA Topoisomerases, Type I ; genetics ; metabolism ; Down-Regulation ; Drug Resistance, Neoplasm ; Humans ; Lung Neoplasms ; metabolism ; pathology ; RNA Interference ; RNA, Messenger ; metabolism ; RNA, Small Interfering ; genetics ; Small Cell Lung Carcinoma ; metabolism ; pathology ; Topotecan ; pharmacology ; Transfection
5.Urinary Aldosterone Concentration: Its Value in Primary Aldosteronism Screening and Comparison of a LC-MS/MS Assay and a CLIA Assay for Its Determination
Jing FAN ; Xiao-yun ZHANG ; Qi-ling FENG ; Ju-ying TANG ; Shao-ling ZHANG ; Feng LI ; Ying GUO ; Li YAN
Journal of Sun Yat-sen University(Medical Sciences) 2020;41(4):563-571
【Objective】 To explore the clinical value of urinary aldosterone concentration(UAC) in primary aldosteronism(PA) screening and to evaluate the consistency of the two methods, liquid chromatography tandem mass spectrometry(LC-MS/MS) and chemiluminescence immunosorbent assay(CLIA), for determining UAC. 【Methods】 Among the 133 patients with suspected PA enrolled from October 2018 to August 2019, 55 were diagnosed with PA(30 with aldosteroneproducing adenoma and 25 with bilateral idiopathic hyperplasia) and 78 with essential hypertension(EH). Parallel determination of UAC was done with LC-MS/MS and CLIA assays on all subjects, then we compared the two methods and evaluated their correlation and consistency. Reciever operating characteristic(ROC) analysis was applied to assess the diagnostic accuracies, area under the curve(AUC) and cutoff values of UAC, plasma aldosterone concentration(PAC), random aldosterone to renin ratio(ARR) and urine aldosterone to renin ratio(UARR). Furthermore, ROC analysis of high urine sodium subgroup(urine sodium≥130 mmol/24h) was performed to evaluate the impact of sodium intake on PA screening. 【Results】 ①UAC
6.Value of Plasma Free Metanephrine and Normetanephrine in the Diagnosis of Pheochromocytoma and Paraganglioma
Yao YAO ; Qi-ling FENG ; Yong-jie LI ; Xiao-yun ZHANG ; Ju-ying TANG ; Ying GUO ; Shao-ling ZHANG ; Li YAN
Journal of Sun Yat-sen University(Medical Sciences) 2022;43(1):107-116
ObjectiveTo explore the value of plasma free metanephrines, including metanephrine(MN) and normetanephrine(NMN), collectively referred to as MNs in the diagnosis of pheochromocytoma and paraganglioma (PPGL). MethodsThe study included 1 631 patients suspected of PPGL from December 2014 to December 2020 in SunYat-sen Memorial Hospital. In these subjects, Plasma free MNs were measured by liquid chromatography-tandem mass spectrometry(LC-MS/MS) before surgery. Receiver operating characteristic (ROC) curves were used to determine the sensitivity and specificity of plasma NMN and MN in the diagnosis of PPGL. ResultsOf the screened patients, 108 patients had pathologically confirmed PPGL and 1 523 patients had definitive diagnoses other than PPGL as a control group. The median value of plasma MN [0.54(0.17~4.48) nmol/L vs. 0.15(0.11~0.21) nmol/L, P<0.001] and NMN [7.48(2.12~15.01) nmol/L vs. 0.32(0.22~0.46) nmol/L, P<0.001] were significant higher in the PPGL group than in the control group. Using an upper cut-off of 0.395 nmol/L for MN, the sensitivity was 60.2% and the specificity was 97.8%; when using a cut-off of 1.105 nmol/L for NMN, the diagnostic sensitivity was 87.0%, and the specificity was 98.7%. The area under the ROC curve and 95% confidence interval of plasma MN and NMN combined were 0.800(0.743, 0.858), 0.959(0.932, 0.98) and 0.970(0.944, 0.996), respectively. Analyzing the false-positive results, it was found that in the control group, 3% of the false-positive cases appeared. The estimated glomerular filtration rate(eGFR) were significantly lower in the false-positive group than in the true-negative group [74.42(51.04~96.96) mL/min vs. 88.51(72.80~101.83) mL/min, P=0.001]. In 212 patients with eGFR lower than 60 mL/min, the false positive rate was increased to 8%. If the upper limit of the reference interval was increased by 25%, the specificity was increased to 96.7%; when the upper limit of the reference interval was increased by 50%, the specificity was 98.6 %. ConclusionsPlasma free MNs has a great reliability in the diagnosis of PPGL. The negative predictive value is extremely high and close to 100%. Combination analysis of plasma MN and NMN can further improve diagnostic performance. However, a few false positive cases may appear and might be influenced by impaired renal function. In patients with eGFR lower than 60 mL/min, the false positive rate is significantly increasing, which need a 25%-50% increase in the expected upper limit of a reference range to guarantee high specificity.
7.Clinical treatment of small hepatocellular carcinoma.
Rong-Ping GUO ; Min-Shan CHEN ; Xiao-Jun LIN ; Ya-Qi ZHANG ; Jin-Qing LI
Acta Academiae Medicinae Sinicae 2006;28(3):318-321
OBJECTIVETo evaluate the suitable treatment methods of small hepatocellular carcinoma (SHCC).
METHODSFrom 2000 to 2004, 849 cases of SHCC (< or = c5 cm) were enrolled and divided into two groups: resection group (n = 406) and minimally invasive treatment (MIT) group (n = 443). The survival rates, recurrence rates, and post-treatment complications were compared retrospectively.
RESULTSThe 3-year survival rate in the resection group was 72.1%. The 3-year survival rates in tumor < or = 3 cm and tumor 3-5 cm of resection group were 73.3% and 70.5% (P = 0.46), respectively. The 1-year, 2-year, and 3-year recurrence rates in resection group were 13.5%, 29.9%, and 39.8%, respectively. The 3-year survival rates in MIT group was 73.8%. The 3-year survival rates in tumor < or = 3 cm and tumor 3-5 cm of MIT group were 74.7% and 72.2% (P = 0.45), respectively. The 1-year, 2-year, and 3-year recurrence rates in MIT group were 12.6%, 28.7%, and 40.4%, respectively. The 3-year survival rate was significantly different between these two group in tumor < or = 3 cm (P < 0.05). The post-treatment complication rates of these two group were 30.8% and 6.1% (P < 0.01), respectively.
CONCLUSIONSMIT is as effective as the traditional resection in SHCC. However, MIT is superior to the traditional resection in terms of minimal invasion and less post treatment complication rate. The recurrence rate of HCC was still high after treatment. Comprehensive therapies, including MIT, may increase the survival rate and life quality in SHCC patients.
Adult ; Aged ; Carcinoma, Hepatocellular ; surgery ; Female ; Hepatectomy ; Humans ; Liver Neoplasms ; surgery ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; prevention & control ; Retrospective Studies ; Survival Rate
8.Echocardiography diagnosis of fetal cardiac structural abnormalities.
Sen YANG ; Qi ZHU ; Jiao CHEN ; Yi-Min HUA ; Kai-Yu ZHOU ; Nan GUO
Chinese Journal of Contemporary Pediatrics 2010;12(2):99-102
OBJECTIVETo investigate the application of echocardiography diagnosis of fetal cardiac structural abnormalities.
METHODSThe echocardiography findings of 9 352 fetus were studied.
RESULTSA total of 472 cases showed cardiac structural abnormalities, including 7 cases of ventricular septal defect, 53 cases of atrioventricular septal defect, 49 cases of atrial septal defect, 26 cases of tetralogy of Fallot, 21 cases of persistent truncus arteriosus, 20 cases of Ebstein's anomaly and 206 cases of other cardiac abnormalities. There were 17 cases with cardiac arrhythmia, 9 with heart failure, and 5 with hydrops.
CONCLUSIONSFetal echocardiography is a promising diagnostic tool for prenatal evaluation of cardiac structural abnormalities. The echocardiography diagnosis and evaluation for fetal congenital cardiovascular malformations is the foundation of the guidance and monitoring in intrauterine fetal cardiac intervention.
Adult ; Arrhythmias, Cardiac ; etiology ; Echocardiography ; Female ; Follow-Up Studies ; Heart Defects, Congenital ; complications ; diagnostic imaging ; Heart Failure ; etiology ; Humans ; Hydrops Fetalis ; etiology ; Pregnancy ; Ultrasonography, Prenatal
9.Application research on quantitative real-time fluorescence quantitative PCR assay for Brucella
Hong-xia, ZHANG ; Wen-xue, QI ; Wen-xing, LIU ; Sen, HU ; Zhan-shui, YU ; Mei-lan, DU ; Wei-guo, XUE ; Zhi-gao, BU
Chinese Journal of Endemiology 2009;28(5):476-479
Objective To discuss a real-time fluorescence quantitative polymerase chain reaction (FQ-PCR) wether if can be used to detect Brucella. Methods According to the BCSP31 gene sequences specific for Brucella, one pair of primers and one TaqMan probe were designed. A real-time PCR was developed with the BCSP31 fragments cloned into PMD18-T vector. The standard cure was established and the sensitivity, the species specificity and the stability of the assay were evaluated. The clinical blood specimens were detected by QT-PCR and compared with clinical diagnosis. Results The standard curve was established with the standard template and the relationship between the Ct and the DNA copy number was linear(r=0.999). The sensitivity of the real-time PCR was 5 copies/μl. The sensitivity of the common PCR was 5×102 copies/μl. The sensitivity was about 100 times higher than common PCR. Species specificity of this FQ-PCR assay evaluated using genomic DNA from 6 Bmcella strains and 5 non-Brucella strains and strong fluorescence was detected in all Brucella strains. The CV of intra-assay and inter-assay reproducibility were 0.71%,7.23%, reprectively. Twenty-four specimens from clinical brucellosis cases, 19 showed positive, the positive coincident rate was 79%(19/24). The negative results were obtained for all 31 negative control, and the negative coincident rate was 100%(31/31). Two were positive from all 30 specimens clinically suspected. Conclusions Highly specific, sensitive, repeatable and coincidental with clinic, this FQ-PCR is quite useful for rapid detection of tiny DNA of Brucella in various samples and laboratory diagnosis.
10.Expression and significance of integrin alpha5, beta1 and E-CD in patients with non-small cell lung carcinoma.
Qi-Sen GUO ; Hui JIA ; Ming-Yong HAN ; Jin-Ming YU ; Wei-Xia ZHONG
Chinese Journal of Oncology 2006;28(10):746-749
OBJECTIVETo investigate the relationship between the expressions of integrin alpha5 beta1 and E-CD, and clinicopathological characteristics and prognosis of patients with non-small cell lung carcinoma (NSCLC).
METHODSThe expression of integrin alpha5 beta1 and E-CD were analyzed in 53 NSCLC and 12 control specimens by immunohistochemical assay.
RESULTSThe expression of integrin alpha5 beta1 was significantly higher in NSCLC (58.5%) than that in normal lung tissue (16.7%), and also positively related with pathological characteristics (P = 0.021), lymph node metastasis (P = 0.006), and clinical stage (P = 0.002). The 3-year survival rate in NSCLC group was significantly lower than that in control group (22.3% vs 40.6% , P = 0.041). The positive expression of E-CD in NSCLC and control group was 32.1% and 91.7%, respectively, and negatively correlated with pathological characteristics (P = 0.010) and lymph node metastasis (P = 0.002). The 3-year survival rate in control group was 19.9%, lower than that in NSCLC group (41.2%, P > 0.05), but the difference is not significant.
CONCLUSIONThe overexpression of integrin alpha5 beta1 may contribute to lymph node metastasis and play an inverse role, while E-CD may be a beneficial prognostic factor in patients with NSCLC.
Adult ; Aged ; Cadherins ; metabolism ; Carcinoma, Non-Small-Cell Lung ; metabolism ; pathology ; Female ; Humans ; Immunohistochemistry ; Integrin alpha5beta1 ; metabolism ; Lung Neoplasms ; metabolism ; pathology ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Staging ; Smoking ; Survival Analysis